Cancer Research Annual Meeting 2010  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yin, J.
Right arrow Articles by Kannagi, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yin, J.
Right arrow Articles by Kannagi, R.
[Cancer Research 66, 2937-2945, March 15, 2006]
© 2006 American Association for Cancer Research


Molecular Biology, Pathobiology, and Genetics

Hypoxic Culture Induces Expression of Sialin, a Sialic Acid Transporter, and Cancer-Associated Gangliosides Containing Non–Human Sialic Acid on Human Cancer Cells

Jun Yin1,2, Ayako Hashimoto1,3, Mineko Izawa1, Keiko Miyazaki1,3, Guo-Yun Chen1,3, Hiromu Takematsu4, Yasunori Kozutsumi4, Akemi Suzuki4, Kimio Furuhata5, Feng-Leng Cheng6, Chun-Hung Lin6, Chihiro Sato2, Ken Kitajima2 and Reiji Kannagi1,3

1 Department of Molecular Pathology, Aichi Cancer Center; 2 Department of Bioengineering Sciences, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya; 3 CREST, Japan Science and Technology Agency, Kawaguchi; 4 Supra-Biomolecular System Research Group, RIKEN Frontier Research System, Saitama; 5 School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan; and 6 Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan

Requests for reprints: Reiji Kannagi, Department of Molecular Pathology, Research Institute, Aichi Cancer Center, 1-1 Kanokoden, Chikusaku, Nagoya 464-8681, Japan. Phone/Fax: 81-52-764-2973; E-mail: rkannagi{at}aichi-cc.jp.

Tumor hypoxia figures heavily in malignant progression by altering the intracellular glucose metabolism and inducing angiogenic factor production, thus, selecting and expanding more aggressive cancer cell clones. Little is known, however, regarding hypoxia-induced antigenic changes in cancers. We investigated the expression of N-glycolyl sialic acid (NeuGc)-GM2, a cancer-associated ganglioside containing non–human sialic acid, NeuGc, in human cancers. Cancer tissues prepared from patients with colon cancers frequently expressed NeuGc-GM2, whereas it was virtually absent in nonmalignant colonic epithelia. Studies on cultured cancer cells indicated that the non–human sialic acid was incorporated from culture medium. Hypoxic culture markedly induced mRNA for a sialic acid transporter, sialin, and this accompanied enhanced incorporation of NeuGc as well as N-acetyl sialic acid. Transfection of cells with sialin gene conferred accelerated sialic acid transport and induced cell surface expression of NeuGc-GM2. We propose that the preferential expression of NeuGc-GM2 in cancers is closely associated with tumor hypoxia. Hypoxic culture of tumor cells induces expression of the sialic acid transporter, and enhances the incorporation of non–human sialic acid from the external milieu. A consequence of this is the acquisition of cancer-associated cell surface gangliosides, typically GM2, containing non–human sialic acid (NeuGc), which is not endogenously synthesized through CMP-N-acetyl sialic acid hydroxylase because humans lack the gene for the synthetic enzyme. As hypoxia is associated with diminished response to radiotherapy and chemotherapy, NeuGc-GM2 is a potential therapeutic target for hypoxic cancer cells. (Cancer Res 2006; 66(6): 2937-45)




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Hedlund, V. Padler-Karavani, N. M. Varki, and A. Varki
Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression
PNAS, December 2, 2008; 105(48): 18936 - 18941.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
V. Padler-Karavani, H. Yu, H. Cao, H. Chokhawala, F. Karp, N. Varki, X. Chen, and A. Varki
Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: Potential implications for disease
Glycobiology, October 1, 2008; 18(10): 818 - 830.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
L. Roque-Navarro, K. Chakrabandhu, J. de Leon, S. Rodriguez, C. Toledo, A. Carr, C. M. de Acosta, A.-O. Hueber, and R. Perez
Anti-ganglioside antibody-induced tumor cell death by loss of membrane integrity
Mol. Cancer Ther., July 1, 2008; 7(7): 2033 - 2041.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Hedlund, P. Tangvoranuntakul, H. Takematsu, J. M. Long, G. D. Housley, Y. Kozutsumi, A. Suzuki, A. Wynshaw-Boris, A. F. Ryan, R. L. Gallo, et al.
N-Glycolylneuraminic Acid Deficiency in Mice: Implications for Human Biology and Evolution
Mol. Cell. Biol., June 15, 2007; 27(12): 4340 - 4346.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.